Regenerative Medical Technology Group net loss widens to US$ 2.91 million in Q2 FY26; revenue rises to US$ 4.02 million

Reuters2026/08/19 21:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Regenerative Medical Technology Group posted Q2 revenue of US$ 4.02 million, up 309.02% year over year; net loss widened to US$ 2.91 million.
Operating income swung to US$ 565,977 from an operating loss; interest expense climbed to US$ 2.23 million, lifting total other expense.
For the six months, revenue rose 183.75% to US$ 6.66 million; net loss widened to US$ 3.22 million.
Cash and cash equivalents increased 38.32% to US$ 1.32 million at June 30, 2026; operating cash flow was US$ 434,098.
Business updates included launches of the ISSCA Mobile App on June 17, 2026, and the ISSCA AI Clinical Intelligence Platform on June 23, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-091797), on August 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Regenerative Medical Technology Group net loss widens to US$ 2.91 million in Q2 FY26; revenue rises to US$ 4.02 million

You may also like

Crypto prices